1-9 of 9
Ranjana Advani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

Clinical Trials & Observations
Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana Advani, Mark Roschewski
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5855–5863.
https://doi.org/10.1182/bloodadvances.2024013277
Published: 2024
Includes: Supplemental data
Journal Articles

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Joseph E. Maakaron, Adam Asch, Leslie Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Gal Hacohen-Kleiman, Yanan Huo, Yi Zhang, Camille Renard, Sonali M. Smith, Ranjana Advani
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5864–5874.
https://doi.org/10.1182/bloodadvances.2024013338
Published: 2024
Includes: Supplemental data
Journal Articles

Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma

Clinical Trials & Observations
Thomas Witzig, Lubomir Sokol, Won Seog Kim, Fátima de la Cruz Vicente, Alejandro Martín García-Sancho, Ranjana Advani, Jose Maria Roncero Vidal, Raquel de Oña Navarrete, Ana Marín-Niebla, Antonia Rodriguez Izquierdo, María José Terol, Eva Domingo-Domenech, Andrew Saunders, Nawal Bendris, Julie Mackey, Mollie Leoni, Francine Foss
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4581–4592.
https://doi.org/10.1182/bloodadvances.2024012806
Published: 2024
Includes: Supplemental data
Journal Articles

A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis

Clinical Trials & Observations
Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe, Susan Grimes, Matthew J. Frank, Lauren S. Maeda, Ash A. Alizadeh, Ranjana Advani, Richard T. Hoppe, Steven R. Long, Brock Martin, Michael G. Ozawa, Michael S. Khodadoust, Hanlee P. Ji, Ronald Levy
Journal: Blood Advances
Blood Adv (2023) 8 (1): 130–142.
https://doi.org/10.1182/bloodadvances.2023011589
Published: 2023
Includes: Supplemental data
Journal Articles

Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma

Clinical Trials & Observations
Pamela B. Allen, Xinyan Lu, Qing Chen, Kaitlyn O’Shea, Joan S. Chmiel, Liron Barnea Slonim, Madina Sukhanova, Hatice Savas, Andrew M. Evens, Ranjana Advani, Barbara Pro, Reem Karmali, Brett Palmer, Robert A. Bayer, Robert M. Eisner, Eric Mou, Gary Dillehay, Leo I. Gordon, Jane N. Winter
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2670–2676.
https://doi.org/10.1182/bloodadvances.2022008116
Published: 2023
Journal Articles

Role of stem cell transplant in CD30 + PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Clinical Trials & Observations
Kerry J. Savage, Steven M. Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trneny, Sam Yuen, Pier Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A. O’Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5550–5555.
https://doi.org/10.1182/bloodadvances.2020003971
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5482–5493.
https://doi.org/10.1182/bloodadvances.2022008355
Published: 2022
Includes: Supplemental data
Journal Articles

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Clinical Trials & Observations
Paola Ghione, Promie Faruque, Neha Mehta-Shah, Venkatraman Seshan, Neval Ozkaya, Shakthi Bhaskar, James Yeung, Michael A. Spinner, Matthew Lunning, Giorgio Inghirami, Alison Moskowitz, Natasha Galasso, Nivetha Ganesan, Carrie van der Weyden, Jia Ruan, H. Miles Prince, Judith Trotman, Ranjana Advani, Ahmet Dogan, Steven Horwitz
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4640–4647.
https://doi.org/10.1182/bloodadvances.2020002396
Published: 2020
Includes: Supplemental data
Journal Articles

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Clinical Trials & Observations
Pallawi Torka, Shalin K. Kothari, Suchitra Sundaram, Shaoying Li, L. Jeffrey Medeiros, Emily C. Ayers, Daniel J. Landsburg, David A. Bond, Kami J. Maddocks, Anshu Giri, Brian Hess, Luu Q. Pham, Ranjana Advani, Yang Liu, Stefan Klaus Barta, Julie M. Vose, Michael C. Churnetski, Jonathon B. Cohen, Madelyn Burkart, Reem Karmali, Joanna Zurko, Amitkumar Mehta, Adam J. Olszewski, Sarah Lee, Brian T. Hill, Timothy F. Burns, Frederick Lansigan, Emma Rabinovich, David Peace, Adrienne Groman, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri
Journal: Blood Advances
Blood Adv (2020) 4 (2): 253–262.
https://doi.org/10.1182/bloodadvances.2019000875
Published: 2020